Biological products
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800125P
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,081
Award facts
- Contract value 100% obligated
- $7,081.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94566, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $7,081.00 in biological products, effective January 23, 2018, with completion targeted for March 23, 2018. Work is performed in Pleasanton, California. The order procures biological products on a firm-fixed-price basis without set-aside designation.
Quick answers
Who was awarded contract HHSN261201800125P?
HHSN261201800125P was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on January 23, 2018.
How much is contract HHSN261201800125P worth?
The government has obligated $7,081 on HHSN261201800125P.
Was contract HHSN261201800125P competed?
The extent of competition for HHSN261201800125P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award